Merck’s cancer star Keytruda could be on its way to an updated label in HER2-positive stomach cancer after showing it can stave off tumor progression in a combination study. Keytruda scored its original gastric cancer approval in 2021 under the FDA’s accelerated…
New biologics in the form of GSK’s Benlysta and AstraZeneca’s Saphnelo have nearly doubled in use for systemic lupus erythematosus (SLE) since 2021 as rheumatologists are starting to shun traditional off-label meds for the autoimmune disease. That’s according…